Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 11, 1999, Pages 3956-3960

  Cook, David M ^a   Ludlam, William H ^a   Cook, Marie B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GROWTH HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0033343113     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.11.3956     Document Type: Article

References (24)

1. An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and pre-menopausal women
2. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations
3. Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women
4. Gender differences in secretory activity of the human somatotrop c (growth hormone) axis
5. Regulation of growth hormone and somatomedin-C in postmenopausal women: Effect of physiological estrogen replacement therapy
6. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women
7. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults
8. A low starting dose of genotropin in growth hormone-deficient adults
9. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset of growth hormone deficiency. A randomized, placebo-controlled trial
10. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH
11. Effects of 2 years of growth hormone treatment on body composition and cardiovascular risk factors in adults with growth hormone deficiency
12. Which adults develop side-effects of growth hormone replacement?
13. Clinical aspects of growth hormone deficiency in adults
14. Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects
15. Impaired growth hormone secretion in the adult population. Relation to age and adiposity
16. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men
17. Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults
18. Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: A double-blind, randomized, placebo-controlled study
19. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the growth hormone research society workshop on adult growth hormone deficiency
20. The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis
21. Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: A dose-finding study
22. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults
23. Growth hormone replacement therapy in adult hypopituitary patients with growth homone deficiency: Combined data from 12 European placebo-controlled clinical trials
24. Which adults develop side-effects from growth hormone replacement?